🔗 Share this article

A senior medical figure was recused from oversight regarding a significant medical study concerning puberty blockers following allegations of preconceived views surfaced.

Alleged Intervention Resulted in Trial Suspension

Per news coverage, Prof Jacob George, a head medical and scientific officer at the regulatory agency, voiced worries that led to the halting of the government-funded clinical study during early 2024.

The regulator announced this weekend that the professor had recused him of any role in the trial after questioning social media comments posted last year emerged.

Content Regarding the Online Posts

In a comment, George referred to writer the Harry Potter author as a “treasure of our time.” Separately, he remarked how “the denial to accept basic scientific reality was worrisome” regarding discussions about a Olympic athlete’s gender.

The regulator clarified that although the comments were made prior to the official position, he had been recused of involvement in the trial as an precaution.

Details Regarding the Halted Clinical Trial

The Pathways trial, which was designed to evaluate the influence of hormone suppressants for adolescents questioning their gender identity, was due to commence enrolling subjects in January.

Yet, the trial was suspended in February when its agency voiced worries regarding the welfare of young participants participating.

• The youngest subjects were expected to be ten to eleven for biological females while eleven to twelve for biological males.
• The research organizers stated at the time that the strict screening procedure suggested participants would almost certainly be of a higher age.
• But, the regulator has now recommended the lowest age limit must be 14 because of an “unquantified risk” for “long-term physical side effects.”

This study aimed to recruit around two hundred and twenty-six young people over the next several years.

Background and a Cass Review

This trial was announced following a suggestion from a major report into youth gender identity services, that found how the quality of research suggesting to demonstrate the benefits of such treatment for youngsters with gender incongruence was low-quality.”

Doctor Hilary Cass, who chaired the report, had earlier said her findings exposed an extremely poor body of research” for the efficacy of such treatments.

She added, “given that there are medical professionals, children as well as parents who believe deeply of the helpful results, research remained the sole method ahead to make sense of the situation.”

Medical Concern of the Action

Dr Max Davie, a consultant paediatrician, said there existed no compelling medical rationale to suspend the study.

“The online comments from Professor George give a transparent view of his personal views on this issue,” he remarked. “He is quite at liberty to hold any beliefs on this subject he may, however what he cannot do is let these views to influence the performance of his regulatory responsibilities.”

He continued: “It must be understood, there is no compelling scientific reason to halt this study. While Prof George’s own views are not the sole possible explanation for the regulator’s unexpected reversal, it is the sole instance where we possess evidence.”

Regulator Response Regarding Next Steps

A MHRA representative stated: “In every medical studies, the MHRA’s foremost duty remains the protection and wellbeing of the volunteers. In line with this duty, complex studies are kept continuously under scrutiny and the agency maintains an active conversation alongside study funders.”

“We has expert scientific, medical and oversight specialists that operate in a collaborative group to make research-informed decisions regarding clinical trials. These individuals are continuing to engage alongside the organizers to work through the subsequent actions constructively.”

“Following the finding regarding social media comments made before he took up his role, Prof Jacob George is recused of any additional involvement on the Pathways study as a precaution.”